CMLTU News and Press, CM Life Sciences III Inc. Unit From 09/13/21

- Updated data presented at IASLC 2021 World Conference on Lung Cancer includes final PFS analysis and preliminary OS results in Stage IV NSCLC EQRx, a new type of pharmaceutical company committed to developing and delivering important new medicines to patients at radically ...

EQRx, a new type of pharmaceutical company committed to developing and delivering important new medicines to patients at radically lower prices, today announced that Alexis Borisy, executive chairman, Melanie Nallicheri, chief executive officer, and Jami Rubin, chief financial officer, ...

Early last year, I wrote about a startup called EQRx, whose stated mission is to provide lower-cost alternatives to existing drugs. In this case, the SPAC is CM Life Sciences III (CMLTU), trading on the NASDAQ under the symbol CMLTU, that will fuse with EQRx in a deal that is expected...

Six multi-billion dollar deals announced last week. VICI Properties acquires MGM Growth Properties for $17.2 billion. Veoneer receives a superior bid from Qualcomm. For further details see: Merger Arbitrage Mondays - Veoneer Receives A Superior Bid From Qualcomm

Anticipated proceeds expand balance sheet to ~$2.0 billion and will be used to accelerate “new pharma” platform to develop and deliver innovative medicines at radically lower prices through unique partnerships with leading payers and healthcare providers Fi...

A team with a track record of prior success has raised its largest SPAC yet. The SPAC is about two months old, meaning it is becoming more likely to do a deal going forward. Because of the track record and the reputation of the team, the warrants are trading relatively rich. ...

CM Life Sciences III Inc. (Nasdaq: CMLTU) (the “ Company ”) today announced that holders of the Company’s units sold in its initial public offering may elect to separately trade the shares of Class A common stock and redeemable warrants included in its units com...

Just two IPOs priced this past week, raising $222 million as the US IPO market continued to cool down. The IPO pipeline remained active, with 13 IPOs and 14 SPACs submitting initial filings this week. Eight blank check companies went public this past week, led by CM Life Sciences ...

CM Life Sciences III Inc. (the “ Company ”) announced today that it closed its initial public offering of 55,200,000 units at $10.00 per unit, including 7,200,000 units issued pursuant to the exercise in full by the underwriters of its over-allotment option. The units ...